The NFY Transcription Factor Mediates Induction of the von Willebrand Factor Promoter by Irradiation

Summary

Ionizing irradiation in patients is proposed to cause thrombus formation. An increase in von Willebrand factor secretion in response to irradiation is a major contributing factor to thrombus formation. We have previously reported that the increased VWF secretion in response to irradiation is mediated at the transcriptional level. The VWF core promoter fragment (sequences –90 to +22) was shown to contain the necessary cis-acting element(s) to mediate the irradiation response of the VWF gene. Here we report that a CCAAT element in the VWF promoter is the cis-acting element necessary for irradiation induction and that the NFY transcription factor interacts with this element. These analyses demonstrate that inhibition of NFY’s interaction with the CCAAT element abolishes the irradiation induction of the VWF promoter. These results provide a novel role for NFY and add this factor to the small list of irradiation-responsive transcription factors. Coimmunoprecipitation experiments demonstrated that NFY is associated with the histone acetylase P/CAF in vivo and that irradiation resulted in an increased association of NFY with coactivator P/CAF. We propose that irradiation induction of the VWF promoter involves a mechanism resulting in increased recruitment of the coactivator P/CAF to the promoter via the NFY transcription factor.

Keywords

NFY - von Willebrand factor - irradiation - promoter

• References

• 1 Baker DG, Krochak RJ. The response of the microvascular system to radiation: a review. Cancer Investig 1989; 7: 287-94.
• 2 Dulic V, Kaufmann WK, Wilson SJ, Tlsty TD, Lees E, Harper JW, Elledge SJ, Reed SI. p53-Dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 1994; 76: 1013-23.
• 3 Kharbanda S, Ren R, Pandey P, Shafman TD, Feller SM, Weichselbaum RR, Kufe DW. Activation of c-Abl tyrosine kinase in the stress response to DNA-damaging agents. Nature 1995; 376: 785-8.
• 4 Witte L, Fuks Z, Haimovitz-Friedman A, Vlodavsky I, Goodman DS, Eldor A. Effects of radiation on the release of growth factors from cultured bovine, porcine and human endothelial cells. Cancer Res 1989; 49: 5066-72.
• 5 Boothman DA, Lee IW, Sahijdak WM. Isolation of an X-ray-responsive element in the promoter region of tissue-type plasminogen activator: Potential uses of X-ray-responsive elements for gene therapy. Radiat Res 1994; 138: S68-S71.
• 6 Zhou Q, Zhou Y, Li P, Bai X, Ruan C. Thrombomodulin as a marker of radiation-induced endothelial cell injury. Radiat Res 1992; 131: 285-9.
• 7 Hong J-H, Chiang C-S, Campbell IL, Sun J-R, Withers HR, McBride WH. Induction of acute phase gene expression by brain irradiation. Int J Radiation Oncology Biol Phys 1995; 33: 619-25.
• 8 Heckmann M, Douwes K, Peter R, Degitz K. Vascular activation of adhesion molecule mRNA and cell surface expression by ionizing radiation. Exp Cell Res 1998; 238: 148-54.
• 9 Onoda JM, Piechocki MP, Honn KV. Radiation-induced increase in expression of the alpha IIb beta3 integrin in melanoma cells: Effects on metastatic potential. Radiat Res 1992; 130: 281-8.
• 10 Sporn IA, Rubin P, Marder VJ, Wagner DD. Irradiation induces release of von Willebrand protein from endothelial cells in culture. Blood 1984; 64: 567-70.
• 11 Verheij M, Dewit LG, Boomgaard MN, Brinkman HJ, van Mourik JA. Ionizing radiation enhances platelet adhesion to the extracellular matrix of human endothelial cells by an increase in the release of von Willebrand factor. Radiat Res 1994; 137: 202-7.
• 12 Sadler JE. Von Willebrand factor. J Biol Chem 1991; 266: 22777-80.
• 13 Denis C, Methia N, Frenette PS, Rayburn H, Ullman-Cullere M, Hynes RO, Wagner DD. A mouse model of severe von Willebrand disease: Defects in hemostasis and thrombosis. Proc Natl Acad Sci USA 1998; 95: 9524-9.
• 14 O’Keefe Jr JH, Conn RD, Lavie CJ, Bateman TM. The new paradigm for coronary artery disease: altering risk factors, atherosclerotic plaques, and clinical prognosis. Mayo Clinic Proceedings. 1996; 71: 957-65.
• 15 Jahroudi N, Ardekani AM, Greenberger JS. Ionizing irradiation increases transcription of the von Willebrand Factor Gene in Endothelial Cells. Blood 1996; 88: 3801-14.
• 16 Jahroudi N, Lynch DC. Endothelial-cell-specific regulation of von Willebrand factor gene expression. Mol Cell Biol 1994; 14: 999-1008.
• 17 Ferreira V, Assouline Z, Schachtgen JL, Bahnak BR, Meyer D, KerbiriouNabias D. The role of the 5′-flanking region in the cell-specific transcription of the human von Willebrand factor gene. Biochem J 1993; 293: 641-8.
• 18 Collins CJ, Underdahl JP, Levene RB, Ravera CP, Morin MJ, Dombalagian MJ, Ricca G, Livingston DM, and Lynch DC. Molecular cloning of the human gene for von Willebrand factor and identification of the transcription initiation site. Proc Natl Acad Sci USA 1987; 84: 4393-7.
• 19 Hallahan DE, Dunphy E, Kuchibhotla J, Kraft A, Unlap T, Weichselbaum RR. Prolonged c-jun expression in irradiated Ataxia-telangiectasia fibro-blasts. Int J Radiat Oncol Biol Phys 1996; 36: 355-60.
• 20 Dichek D, Quertermous T. Variability in messenger RNA levels in human umbilical vein endothelial cells of different lineage and time in culture. In Vitro Cell Dev Biol 1989; 25: 289-92.
• 21 Schreiber E, Matthias P, Muller M, Schaffner W. Rapid detection of octamer binding proteins with “mini-extracts”, prepared from a small number of cells. Nucleic Acids Res 1989; 17: 6419.
• 22 Zhan Q, Chen IT, Antinore MJ, Fornace Jr AJ. Tumor suppressor p53 can participate in transcriptional induction of the GADD45 promoter in the absence of direct DNA binding. Mol Cell Biol 1998; 18: 2768-78.
• 23 Wedel A, Ziegler-Heitbrock HML. The C/EBP family of transcription factors. Immunobiol 1995; 193: 171-85.
• 24 Dorn A, Bollekens J, Staub A, Benoist C, Mathis D. A multiplicity of CCAAT box-binding proteins. Cell 1987; 50: 863-72.
• 25 MacDougald OA, Lane MD. Transcriptional regulation of gene expression during adipocyte differentiation. Annu Rev Biochem 1995; 64: 345-73.
• 26 Superti-Furga G, Barberis A, Schreiber E, Busslinger M. The protein CDP, but not CP1, footprints on the CCAAT region of the gamma-globin gene in unfractionated B-cell extracts. Biochim Biophys Acta 1989; 1007: 237-42.
• 27 Lievens PM, Donady JJ, Tufarelli C, Neufeld EJ. Repressor activity of CCAAT displacement protein in HL-60 myeloid leukemia cells. J Biol Chem 1995; 270: 12745-50.
• 28 Maity SN, Golumbek PT, Karsenty G, de Crombrugghe B. Selective activation of transcription by a novel CCAAT binding factor. Science 1988; 241: 582-5.
• 29 Linhoff MW, Wright KL. Ting J P. CCAAT-binding factor NF-Y and RFX are required for in vivo assembly of a nucleoprotein complex that spans 250 base pairs: the invariant chain promoter as a model. Mol Cell Biol 1997; 17: 4589-96.
• 30 Ishimaru F, Mari B, Shipp MA. The type 2 CD10/neutral endopeptidase 24.11 promoter: functional characterization and tissue-specific regulation by CBF/NF-Y isoforms. Blood 1997; 89: 4136-45.
• 31 Chang ZF, Liu CJ. Human thymidine kinase CCAAT-binding protein is NF-Y, whose A subunit expression is serum-dependent in human IMR-90 diploid fibroblasts. J Biol Chem 1994; 269: 17893-8.
• 32 Nakshatri H, Bhat-Nakshatri P, Currie RA. Subunit association and DNA binding activity of the heterotrimeric transcription factor NF-Y is regulated by cellular redox. J Biol Chem 1996; 271: 28784-91.
• 33 Jin S, Scotto K. Transcriptional regulation of the MDR1 gene by histone acetyltransferase and deacetylase is mediated by NF-Y. Mol Cell Biol 1998; 18: 4377-84.
• 34 Raymond J, Yoon S-C, Ts’ao C-H. Stimulation of radiation-impaired plasminogen activator release by phorbol ester in aortic endothelial cells. Proc Soc Exp Biol Med 1990; 195: 213-7.
• 35 Brach MA, Hass R, Sherman ML, Gunji H, Weichselbaum RR, Kufe DW. Ionizing irradiation induces expression and binding activity of the nuclear factor kappa B. J Clin Investig 1991; 88: 691-5.
• 36 Kastan MB, Zhan Q, El-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B, Fornace Jr AJ. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in Ataxia-Telangiectasia. Cell 1992; 71: 587-97.
• 37 Datta R, Rubin E, Sukhatme V, Qureshi S, Hallahan DE, Weichselbaum RR, Kufe DW. Ionizing radiation activates transcription of the egr-1 gene via CArG elements. Proc Natl Acad Sci USA 1992; 89: 10149-53.
• 38 Sherman ML, Datta R, Hallahan DE, Weichselbaum RR, Kufe DW. Ionizing radiation regulates expression of the c-jun protooncogene. Proc Natl Acad Sci USA 1990; 87: 5663-6.
• 39 Liu L, Scolnick DM, Trievel RC, Zhang HB, Marmorstein R, Halazonetis TD, Berger SL. P53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage. Mol Cell Biol 1999; 19: 1202-9.
• 40 Faniello MC, Bevilacqua MA, Condorelli G, de Crombrugghe Maity SN, Avvedimento VE, Cimino F, Costanzo F. The B subunit of the CAAT-binding factor NFY binds the central segment of the co-activator p300. J Biol Chem 1999; 274: 7623-6.